Sept 3 (Reuters) - Medison Biotech:
* MEDISON BIOTECH THAT OWNS OVER 7.5% OF KNIGHT THERAPEUTICS COMMENTED ON RECENT CLAIMS BROUGHT AGAINST VARIOUS PHARMA COS IN U.S. & CANADA
* MEDISON BIOTECH - URGE KNIGHT THERAPEUTICS' GOODMAN TO EXPLORE POSSIBLE PURCHASES OF ASSETS FROM PHARMA COS THAT ARE UNDER OPIODS-RELATED LEGAL ACTION